APP and Alzheimer disease: These negative impacts of HIF-1α in the microvasculature of AD, along with the aforementioned HIF-1 effects on APP processing and Aβ production/degradation, may further impair vascular function in AD and compromise BBB function, leading to impaired Aβ clearance [204].